Dr. Rahul Naithani

• Established and scaled the Hematology & BMT program at Max Healthcare, leading to over 650 successful bone marrow transplants
• Executive Editor of the Indian Journal of Hematology & Blood Transfusion
• Executive Committee Member of the Indian Society of Hematology & Transfusion Medicine (ISHTM)
• Prolific researcher with a strong publication record: over 120–140 articles in peer-reviewed national and international medical journals

• MBBS — BRD Medical College, Gorakhpur (Deen Dayal Upadhyay University)
• MD (Paediatrics) — Lady Hardinge Medical College, New Delhi (completed in 2004)
• DM (Clinical Hematology) — All India Institute of Medical Sciences (AIIMS), New Delhi (completed in 2009)
• Fellowship in Bone Marrow Transplantation — The Hospital for Sick Children (SickKids), Toronto, Canada
• Bone Marrow Transplant (BMT) Training — St. Jude Children’s Research Hospital, Memphis, USA
• Fellow of the Royal College of Physicians (FRCP) — Edinburgh

Current Role

• Chief – Hematology, Oncology & BMT, Artemis Hospital, Gurugram (current position)

Previous Roles

• Director & Head – Hematology & BMT, Paras Hospital, Gurugram (2023–2024)
• Director & Head – Hematology & BMT, Max Super Speciality Hospital (Saket), New Delhi (2011–2023)
• Chief Fellow – Pediatric Hematology/Oncology, The Hospital for Sick Children (SickKids), University of Toronto (2009–2011)
• Specialist Registrar – Hematology, AIIMS, New Delhi (2004–2008)

• Indian Society of Hematology & Transfusion Medicine (ISHTM)
• Royal College of Physicians, Edinburgh
• European Society for Blood and Marrow Transplantation (EBMT)
• Indian Journal of Hematology & Blood Transfusion – Executive Editor
• Indian Academy of Pediatrics (IAP)
• Children’s Oncology Group (COG)
• American Society of Pediatric Hematology-Oncology (ASPHO)

International Patients Trust Dr. Rahul Naithani for his unmatched expertise in hematology, pediatric and adult hemato-oncology, and bone marrow transplantation, including complex stem cell transplants, management of blood cancers, and advanced treatments for rare blood disorders. He has earned the confidence of patients from UAE, Gulf countries, CIS countries, Africa, Yemen and beyond.

Q1. How many years of experience does Dr. Rahul Naithani have?

He has nearly two decades of expertise in hematology, hemato-oncology, and bone marrow transplantation.

Q2. Where does Dr. Rahul Naithani currently practice?

He is the Chief of Hematology, Oncology & Bone Marrow Transplant at Artemis Hospital, Gurugram, India.

Q3. Is Dr. Rahul Naithani experienced in pediatric bone marrow transplants?

Yes, he is extensively trained in both pediatric and adult bone marrow transplantation, with advanced fellowships from Canada and the USA.

Q4. Can international patients consult Dr. Rahul Naithani easily?

Yes, patients from around the world can book appointments with full assistance for medical visa, travel, and stay arrangements through Regimen Healthcare by Call/Whatsapp: at +91-9310356465 or Emailing: query@regimenhealthcare.com.

Q5. Why do international patients trust Dr. Rahul Naithani?

Because of his global training, high success rates in complex cases, compassionate care, and proven expertise in advanced hematology treatments.

Experience advanced hematology and oncology care, including bone marrow transplantation, treatment of leukemia, lymphoma, myeloma, aplastic anemia, pediatric blood disorders, and complex hemato-oncology cases, from one of India’s most trusted and internationally recognized specialists.

Call or WhatsApp: +91-9310356465

Email: query@regimenhealthcare.com

Get a personalized treatment plan with complete support for medical visa, travel, and comfortable stay arrangements.

Dr. Rahul Naithani consults at Artemis Hospital, Sector 51, Gurgaon, just:

• 25 minutes from Indira Gandhi International Airport, New Delhi
• 20 minutes from Gurgaon Railway Station
• 15 minutes from HUDA City Centre Metro Station (Yellow Line connectivity)
• Surrounded by premium hotels, serviced apartments, pharmacies, and diagnostic centers for international patient convenience